RT @hiroirohiro33: 遺伝子発現に基づくトリプルネガティブ乳がんの4つのサブタイプへの分類と治療戦略。 1)アンドロゲン受容体陽性型 LAR 2)免疫調節型 IM 3)basal-likeかつ免疫抑制型 BLIS 4)間葉系型 MES これまで白人等では報告があ…
RT @hiroirohiro33: 遺伝子発現に基づくトリプルネガティブ乳がんの4つのサブタイプへの分類と治療戦略。 1)アンドロゲン受容体陽性型 LAR 2)免疫調節型 IM 3)basal-likeかつ免疫抑制型 BLIS 4)間葉系型 MES これまで白人等では報告があ…
Genomic and Transcriptomic Landscape of Triple-Negative Breast Cancers: Subtypes and Treatment Strategies|https://t.co/AB5avmTe6b https://t.co/stjlcQdajX
RT @Cancer_Cell: Shi, Huang, Shao & co characterize the clinical, genomic, & transcriptomic landscape of East Asian primary triple-negative…
RT @Cancer_Cell: Shi, Huang, Shao & co characterize the clinical, genomic, & transcriptomic landscape of East Asian primary triple-negative…
Shi, Huang, Shao & co characterize the clinical, genomic, & transcriptomic landscape of East Asian primary triple-negative breast cancers, identify differences with non-Asian TNBCs, classify into subtypes, & reveal candidate therapeutic targets
465 Chinese TNBC omic analysis shows that there is more LAR subtype with ERBB2 somatic mutations, infrequent mutational signature 3 and frequent CDKN2A loss. Is the genomic profile different depending on demographics? #bcsm https://t.co/9Yn7mE3Q2w
Genomic and Transcriptomic Landscape of Triple-Negative Breast Cancers: Subtypes and Treatment Strategies https://t.co/MN6bTu9wMn
RT @StoverLab: Massive multi-omic characterization of 465 TNBCs from @FudanUniversity Shanghai Cancer Ctr - out in @Cancer_Cell -TNBC subty…
RT @StoverLab: Massive multi-omic characterization of 465 TNBCs from @FudanUniversity Shanghai Cancer Ctr - out in @Cancer_Cell -TNBC subty…
RT @StoverLab: Massive multi-omic characterization of 465 TNBCs from @FudanUniversity Shanghai Cancer Ctr - out in @Cancer_Cell -TNBC subty…
RT @StoverLab: Massive multi-omic characterization of 465 TNBCs from @FudanUniversity Shanghai Cancer Ctr - out in @Cancer_Cell -TNBC subty…
RT @StoverLab: Massive multi-omic characterization of 465 TNBCs from @FudanUniversity Shanghai Cancer Ctr - out in @Cancer_Cell -TNBC subty…
Massive multi-omic characterization of 465 TNBCs from @FudanUniversity Shanghai Cancer Ctr - out in @Cancer_Cell -TNBC subtype distribution distinct in Chinese population vs TCGA -Incredible resource to further dissect TNBCs https://t.co/NGveu7Dg6H #TNBC
RT @NatRevClinOncol: Researchers build the genomic and transcriptomic landscape of 465 primary TNBCs from Chinese patients https://t.co/4WH…
RT @Cancer_Cell: Shi, Huang, Shao & co. characterize the clinical, genomic, and transcriptomic landscape of a cohort of 465 primary triple-…
RT @NatRevClinOncol: Researchers build the genomic and transcriptomic landscape of 465 primary TNBCs from Chinese patients https://t.co/4WH…
Genomic and Transcriptomic Landscape of Triple-Negative Breast Cancers: Subtypes and Treatmen... https://t.co/c6shUE6MMj
RT @NatRevClinOncol: Researchers build the genomic and transcriptomic landscape of 465 primary TNBCs from Chinese patients https://t.co/4WH…
RT @NatRevClinOncol: Researchers build the genomic and transcriptomic landscape of 465 primary TNBCs from Chinese patients https://t.co/4WH…
RT @NatRevClinOncol: Researchers build the genomic and transcriptomic landscape of 465 primary TNBCs from Chinese patients https://t.co/4WH…
Researchers build the genomic and transcriptomic landscape of 465 primary TNBCs from Chinese patients https://t.co/4WH3IgNUBF
RT @Epigenomica_mx: Análisis Multi-Omico en #cancer de #mama Triple negativo, Perspectivas para nuevos #biomarcadores y #fármacos: Genomic…
#CANCER #BREAST #WAITINGFORGODOT Genomic and Transcriptomic Landscape of Triple-Negative Breast Cancers: Subtypes and Treatment Strategies https://t.co/DL1nDRyZ4v
Now online at Cancer Cell: Genomic and Transcriptomic Landscape of Triple-Negative Breast Cancers: Subtypes and Treatment Strategies https://t.co/PwEAx6j5gi
RT @Carly_Harro: Genomic and Transcriptomic Landscape of Triple-Negative Breast Cancers: Subtypes and Treatment Strategies https://t.co/YSd…
Genomic and Transcriptomic Landscape of Triple-Negative Breast Cancers: Subtypes and Treatment Strategies https://t.co/YSdVIzTlpr
Genomic and Transcriptomic Landscape of #TNBC: Subtypes and Treatment Strategies https://t.co/uZYfKdcrc9
Análisis Multi-Omico en #cancer de #mama Triple negativo, Perspectivas para nuevos #biomarcadores y #fármacos: Genomic and Transcriptomic Landscape of Triple-Negative Breast Cancers: Subtypes and Treatment Strategies https://t.co/M6pOmNbldu #TNBC #transcri
Genomic and Transcriptomic Landscape of Triple-Negative Breast Cancers: Subtypes and Treatment Strategies https://t.co/CpX5q7eeBY
RT @Cancer_Cell: Shi, Huang, Shao & co. characterize the clinical, genomic, and transcriptomic landscape of a cohort of 465 primary triple-…
Genomic and Transcriptomic Landscape of Triple-Negative Breast Cancers: Subtypes and Treatment Strategies https://t.co/QNNF4Skvw5
RT @notSoJunkDNA: Genomic and Transcriptomic Landscape of Triple-Negative Breast Cancers: Subtypes and Treatment Strategies https://t.co/N4…
RT @Cancer_Cell: Shi, Huang, Shao & co. characterize the clinical, genomic, and transcriptomic landscape of a cohort of 465 primary triple-…
RT @Cancer_Cell: Shi, Huang, Shao & co. characterize the clinical, genomic, and transcriptomic landscape of a cohort of 465 primary triple-…
RT @Cancer_Cell: Shi, Huang, Shao & co. characterize the clinical, genomic, and transcriptomic landscape of a cohort of 465 primary triple-…
@drMKalimutho
RT @Cancer_Cell: Shi, Huang, Shao & co. characterize the clinical, genomic, and transcriptomic landscape of a cohort of 465 primary triple-…
Genomic and Transcriptomic Landscape of Triple-Negative Breast Cancers: Subtypes and Treatment Strategies https://t.co/N4VgSfZ9YZ https://t.co/8VH5PXMJZ5
Cancer Precision Medicine Advancing Science and Medicine
RT @Cancer_Cell: Shi, Huang, Shao & co. characterize the clinical, genomic, and transcriptomic landscape of a cohort of 465 primary triple-…
RT @Cancer_Cell: Shi, Huang, Shao & co. characterize the clinical, genomic, and transcriptomic landscape of a cohort of 465 primary triple-…
Shi, Huang, Shao & co. characterize the clinical, genomic, and transcriptomic landscape of a cohort of 465 primary triple-negative breast cancers to identify transcriptome-based subtypes and candidate therapeutic targets https://t.co/ZfFW8KbZEc https:/